North East and North Cumbria
ICS Formulary
 
back
13 Skin

Specials Recommended by the British Association of Dermatologists for Skin Disease

Most prescribing uses licensed medicines whose safety and efficacy are assured. For many common dermatological diseases including psoriasis and eczema, the range of licensed medicines is limited. As a result, Dermatology prescribing may rely significantly on unlicensed creams and ointments (known as ‘Specials’) containing tars, dithranol, salicylic acid, steroids and other active constituents in a range of concentrations and bases. This is of particular concern in primary care where lack of effective price controls and a mechanism to ensure independent scrutiny of product quality has increased costs and concern about standards. To address these concerns, and help optimise quality of care, adherence to the revised British Association of Dermatologists (BAD) list of preferred Specials (2018) is encouraged.

13-14-07 Miscellaneous

Birch bark extract Filsuvez®
Formulary
  • Gel
  • Approved for treating partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in people aged 6 months and over in line with NICE 
Link  NICE HST28: Birch bark extract for treating epidermolysis bullosa

Red View adult BNF  View SPC online  View childrens BNF  HCD
Difelikefalin Kapruvia®
Formulary
  • 50mcg/1ml solution for injection
  • Approved for pruritus in adults with chronic kidney disease having haemodialysis in line with NICE

Red View adult BNF  View SPC online  View childrens BNF  HCD
Afamelanotide Scenesse®
Non Formulary
  • 16 mg implant
  • Afamelanotide is not recommended for preventing phototoxicity in adults with erythropoietic protoporphyria (EPP) in line with NICE.
Link  NICE HST27: Afamelanotide for treating erythropoietic protoporphyria

Not Recomended View adult BNF  View SPC online  View childrens BNF